Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 54, No. 2, 2008
Issue release date: May 2008
Section title: Experimental Section
Free Access
Gerontology 2008;54:92–99
(DOI:10.1159/000129697)

Senescence, Apoptosis or Autophagy?

When a Damaged Cell Must Decide Its Path – A Mini-Review

Vicencio J.M.a-d · Galluzzi L.a-c · Tajeddine N.a-c · Ortiz C.a, c, d · Criollo A.a-d · Tasdemir E.a-c · Morselli E.a-c · Ben Younes A.a-c · Maiuri M.C.a, b, e · Lavandero S.d · Kroemer G.a-c
aINSERM, U848, bInstitut Gustave Roussy and cUniversité Paris-Sud, Paris, France; dUniversidad de Chile, Facultades de Ciencias Químicas Farmacéuticas y de Medicina, Centro FONDAP Estudios Moleculares de la Célula, Santiago, Chile; eUniversità degli Studi di Napoli Federico II, Facoltà di Scienze Biotecnologiche, Napoli, Italy
email Corresponding Author

Dr. Guido Kroemer

INSERM U848, Institut Gustave Roussy, PR1

39, rue Camille Desmoulins

FR–94805 Villejuif (France)

Tel. +33 1 42 11 60 46, Fax +33 1 42 11 66 55, E-Mail kroemer@igr.fr


References

  1. Campisi J, d’Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007;8:729–740.
  2. van Heemst D, den Reijer PM, Westendorp RG: Ageing or cancer: a review on the role of caretakers and gatekeepers. Eur J Cancer 2007;43:2144–2152.
  3. Bassett CN, Montine TJ: Lipoproteins and lipid peroxidation in Alzheimer’s disease. J Nutr Health Aging 2003;7:24–29.
  4. Butterfield DA, Sultana R: Redox proteomics identification of oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 2007;12:61–72.
  5. Hamilton ML, Van Remmen H, Drake JA, et al: Does oxidative damage to DNA increase with age? Proc Natl Acad Sci USA 2001;98:10469–10474.
  6. Butterfield DA, Kanski J: Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 2001;122:945–962.
  7. Rojo L, Sjoberg MK, Hernandez P, et al: Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer’s disease. J Biomed Biotechnol 2006;1–17.
    External Resources
  8. Williams A, Jahreiss L, Sarkar S, et al: Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 2006;76:89–101.
  9. Itahana K, Campisi J, Dimri GP: Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007;371:21–31.
  10. Kurz T, Terman A, Brunk UT: Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophys 2007;462:220–230.
  11. Helmbold H, Deppert W, Bohn W: Regulation of cellular senescence by Rb2/p130. Oncogene 2006;25:5257–5262.
  12. Vaziri H, Benchimol S: Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase. Oncogene 1999;18:7676–7680.
  13. Kapic A, Helmbold H, Reimer R, et al: Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 2006;13:324–334.
  14. Maddika S, Ande SR, Panigrahi S, et al: Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007;10:13–29.
  15. Yurkova N, Shaw J, Blackie K, et al: The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 2007, E-pub ahead of print.
  16. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99–163.
  17. Pollack M, Phaneuf S, Dirks A, et al: The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann NY Acad Sci 2002;959:93–107.
  18. Galluzzi L, Maiuri MC, Vitale I, et al: Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007;14:1237–1243.
  19. Kroemer G: Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 2003;304:433–435.
  20. Martinou JC, Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001;2:63–67.
  21. Ferri KF, Kroemer G: Mitochondria – the suicide organelles. Bioessays 2001;23:111–115.
  22. Zamzami N, El Hamel C, Maisse C, et al: Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000;19:6342–6350.
  23. Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science 2004;305:626–629.
  24. Choi C, Benveniste EN: Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 2004;44:65–81.
  25. Dietrich N, Thastrup J, Holmberg C, et al: JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ 2004;11:301–313.
  26. Boya P, Andreau K, Poncet D, et al: Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003;197:1323–1334.
  27. Nelyudova A, Aksenov N, Pospelov V, et al: By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal. Cell Cycle 2007;6:2171–2177.
  28. Rebbaa A, Zheng X, Chou PM, et al: Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 2003;22:2805–2811.
  29. Gorbunova V, Seluanov A, Pereira-Smith OM: Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem 2002;277:38540–38549.
  30. Massard C, Zermati Y, Pauleau AL, et al: hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 2006;25:4505–4514.
  31. Seluanov A, Gorbunova V, Falcovitz A, et al: Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol Cell Biol 2001;21:1552–1564.
  32. Seoane J, Le HV, Massague J: Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002;419:729–734.
  33. Cuervo AM: Autophagy: many paths to the same end. Mol Cell Biochem 2004;263:55–72.
  34. Klionsky DJ, Cuervo AM, Dunn WA Jr, et al: How shall I eat thee? Autophagy 2007;3:413–416.
  35. Xie Z, Klionsky DJ: Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007;9:1102–1109.
  36. Pattingre S, Tassa A, Qu X, et al: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122:927–939.
  37. Maiuri MC, Le Toumelin G, Criollo A, et al: Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. Embo J 2007;26:2527–2539.
  38. Galluzzi L, Vicencio J, Kepp O, et al: To die or not to die: that is the autophagic question. Curr Mol Med 2008, in press.
  39. Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell 2008;132:27–42.
  40. Farre JC, Subramani S: Peroxisome turnover by micropexophagy: an autophagy-related process. Trends Cell Biol 2004;14:515–523.
  41. Dice JF, Terlecky SR: Targeting of cytosolic proteins to lysosomes for degradation. Crit Rev Ther Drug Carrier Syst 1990;7:211–233.
  42. Kouchi Z, Sorimachi H, Suzuki K, et al: Proteasome inhibitors induce the association of Alzheimer’s amyloid precursor protein with Hsc73. Biochem Biophys Res Commun 1999;254:804–810.
  43. Shimizu S, Kanaseki T, Mizushima N, et al: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004;6:1221–1228.
  44. Maiuri MC, Zalckvar E, Kimchi A, et al: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007;8:741–752.
  45. Demasters G, Di X, Newsham I, et al: Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 2006;5:2786–2797.
  46. Hansen K, Wagner B, Hamel W, et al: Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells. J Neurochem 2007;103:259–275.
  47. Maclean KH, Dorsey FC, Cleveland JL, et al: Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 2008;118:79–88.
  48. Reef S, Kimchi A: A smARF way to die: a novel short isoform of p19ARF is linked to autophagic cell death. Autophagy 2006;2:328–330.
  49. Zaidi AU, McDonough JS, Klocke BJ, et al: Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol 2001;60:937–945.
  50. Gerland LM, Peyrol S, Lallemand C, et al: Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp Gerontol 2003;38:887–895.
  51. Stroikin Y, Dalen H, Brunk UT, et al: Testing the ‘garbage’ accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy. Biogerontology 2005;6:39–47.
  52. Terman A, Dalen H, Eaton JW, et al: Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp Gerontol 2003;38:863–876.
  53. Terman A, Brunk UT: The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ 2005;14:107–114.
  54. Kaushik S, Cuervo AM: Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 2006;27:444–454.
  55. Kaushik S, Kiffin R, Cuervo AM: Chaperone-mediated autophagy and aging: a novel regulatory role of lipids revealed. Autophagy 2007;3:387–389.
  56. Massey AC, Kiffin R, Cuervo AM: Autophagic defects in aging: looking for an ‘emergency exit’? Cell Cycle 2006;5:1292–1296.
  57. Nishiyama J, Miura E, Mizushima N, et al: Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death. Autophagy 2007;3:591–596.
  58. Hara T, Nakamura K, Matsui M, et al: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006;441:885–889.
  59. Komatsu M, Waguri S, Chiba T, et al: Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006;441:880–884.
  60. Lum JJ, Bauer DE, Kong M, et al: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005;120:237–248.
  61. Bergamini E, Cavallini G, Donati A, et al: The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction. Ann NY Acad Sci 2007;1114:69–78.
  62. Morck C, Pilon M: Caloric restriction and autophagy in Caenorhabditis elegans. Autophagy 2007;3:51–53.
  63. Bishop NA, Guarente L: Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet 2007;8:835–844.
  64. Mathew R, Karantza-Wadsworth V, White E: Role of autophagy in cancer. Nat Rev Cancer 2007;7:961–967.